Drug Lynparza Helps Fight Some Early-Stage Breast Cancers
By Dennis Thompson HealthDay Reporter FRIDAY, June 4, 2021 (HealthDay News) — A twice-daily pill can dramatically reduce the risk of breast cancer recurrence in women who are genetically prone to the disease, researchers report. The pill — olaparib (Lynparza) — works by blocking a natural enzyme called PARP … Read more